KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAssetsCash & EquivalentsCommon EquityCurrent AssetsGoodwillGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNotes PayablesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Cme Group (CME) Other Accumulated Expenses: 2009-2025

Historic Other Accumulated Expenses for Cme Group (CME) over the last 17 years, with Sep 2025 value amounting to $471.1 million.

  • Cme Group's Other Accumulated Expenses fell 2.91% to $471.1 million in Q3 2025 from the same period last year, while for Sep 2025 it was $471.1 million, marking a year-over-year decrease of 2.91%. This contributed to the annual value of $2.6 billion for FY2024, which is 17.39% down from last year.
  • Per Cme Group's latest filing, its Other Accumulated Expenses stood at $471.1 million for Q3 2025, which was down 13.48% from $544.5 million recorded in Q2 2025.
  • Cme Group's 5-year Other Accumulated Expenses high stood at $3.1 billion for Q4 2023, and its period low was $379.1 million during Q2 2021.
  • Over the past 3 years, Cme Group's median Other Accumulated Expenses value was $625.5 million (recorded in 2025), while the average stood at $1.0 billion.
  • Its Other Accumulated Expenses has fluctuated over the past 5 years, first tumbled by 43.63% in 2021, then surged by 39.40% in 2022.
  • Quarterly analysis of 5 years shows Cme Group's Other Accumulated Expenses stood at $1.7 billion in 2021, then spiked by 39.40% to $2.3 billion in 2022, then spiked by 36.20% to $3.1 billion in 2023, then dropped by 17.39% to $2.6 billion in 2024, then fell by 2.91% to $471.1 million in 2025.
  • Its Other Accumulated Expenses stands at $471.1 million for Q3 2025, versus $544.5 million for Q2 2025 and $625.5 million for Q1 2025.